NCT05783310

Brief Summary

This randomized controlled trial aims to evaluate the effectiveness of the psychoeducation intervention on anxiety, depressive symptoms, coping, and HRQoL in caregivers of children with cancer. The study is a two-arm parallel-group single-blind, randomized controlled trial that will be conducted in two hospitals in Malawi.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
118

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started May 2023

Shorter than P25 for not_applicable

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 2, 2023

Completed
22 days until next milestone

First Posted

Study publicly available on registry

March 24, 2023

Completed
2 months until next milestone

Study Start

First participant enrolled

May 22, 2023

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 30, 2023

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2023

Completed
Last Updated

February 20, 2024

Status Verified

February 1, 2024

Enrollment Period

6 months

First QC Date

March 2, 2023

Last Update Submit

February 15, 2024

Conditions

Keywords

AnxietyCancerCaregiversChildrenCopingDepressive symptomHealth-related quality of lifePsychoeducation intervention

Outcome Measures

Primary Outcomes (3)

  • Anxiety level

    Anxiety will be measured using the General Anxiety Disorder questionnaire (GAD-7) GAD-7 is a 7-item scale that assesses anxiety symptoms on a 4-point scale (0=not at all to 3=nearly every day). The final score is determined by summing the scores for the seven items. Scores 5, 10, and 15 represent the cut-off points for mild, moderate, and severe anxiety, respectively.

    Baseline

  • Anxiety level

    Anxiety will be measured using the General Anxiety Disorder questionnaire (GAD-7) GAD-7 is a 7-item scale that assesses anxiety symptoms on a 4-point scale (0=not at all to 3=nearly every day). The final score is determined by summing the scores for the seven items. Scores 5, 10, and 15 represent the cut-off points for mild, moderate, and severe anxiety, respectively.

    Post-intervention at six weeks

  • Anxiety level

    Anxiety will be measured using the General Anxiety Disorder questionnaire (GAD-7) GAD-7 is a 7-item scale that assesses anxiety symptoms on a 4-point scale (0=not at all to 3=nearly every day). The final score is determined by summing the scores for the seven items. Scores 5, 10, and 15 represent the cut-off points for mild, moderate, and severe anxiety, respectively.

    Three months post-intervention

Secondary Outcomes (3)

  • Depressive symptoms

    Baseline, immediately after intervention and three months follow up

  • Health-related quality of life

    Baseline, immediately after intervention and three months follow up

  • Coping

    Baseline, immediately after intervention and three months follow up

Study Arms (2)

Psychoeducation Intervention

EXPERIMENTAL

The intervention group will receive six sessions of a psychoeducation intervention delivered face-to-face

Behavioral: Psychoeducation Intervention

Control group

NO INTERVENTION

No psychoeducation intervention will be given

Interventions

The participants in the intervention group will receive six sessions of psychoeducation intervention, lasting 60 minutes per session for six weeks. The intervention will be provided face-to-face using lectures and discussions. There will also be sharing of experience by the caregivers of children with cancer and a sharing by a caregiver of a childhood cancer survivor. The group format has been chosen to enable caregivers to offer emotional support to each other. The intervention has four components: cancer education, coping skills training, stress management techniques training, and psychological support. The intervention group will also receive the usual care.

Psychoeducation Intervention

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Caregivers will be included if the child is within the one-year post-cancer diagnosis and on treatment, the primary carer of the child, the child is aged ≤ 15 years, caregivers are above 18 years, and caregivers must have a score of more than five on GAD-7 score. A score of 5 is the cut-off point for anxiety in this questionnaire.

You may not qualify if:

  • Caregivers of children with other co-morbidities will be excluded from the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Queen Elizabeth Central Hospital

Blantyre, Malawi

Location

Kamuzu Central Hospital

Lilongwe, Malawi

Location

MeSH Terms

Conditions

NeoplasmsAnxiety DisordersDepression

Condition Hierarchy (Ancestors)

Mental DisordersBehavioral SymptomsBehavior

Study Officials

  • William LI

    The Nethersole School of Nursing, Chinese University of Hong Kong

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
The data collection research assistant will be blinded to the participant's allocation group to avoid the risk of assessor bias.
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: Parallel assignment
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

March 2, 2023

First Posted

March 24, 2023

Study Start

May 22, 2023

Primary Completion

November 30, 2023

Study Completion

December 30, 2023

Last Updated

February 20, 2024

Record last verified: 2024-02

Data Sharing

IPD Sharing
Will not share

Locations